| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | Director
2 companies
Marc D Beer is Executive Chairman at BTMD, with reported holdings spanning 2 companies. Marc D Beer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $405K at current prices.
Marc D Beer's largest disclosed position is in BTMD as Executive Chairman, worth about $288K. The BTMD filings lean toward selling, a net 625,640 shares.
Marc D Beer has 15 Form 4 filings on record from February 2015 to August 2026, across 2 companies: Executive Chairman at biote (BTMD), 2022–2026; Director at Minerva Neurosciences (NERV), 2015–2018.
The 31 reported transactions were 15 option or other derivative awards, 5 open-market purchases, 5 dispositions back to the company and 3 other transactions, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $1.0M and 1 sale worth about $2.6M.
The largest open-market purchase was 107,794 shares of BTMD at an average $3.87 on March 17, 2025, about $417K. Twelve months later BTMD was down 66%.
The only open-market sale was 865,384 shares of BTMD at an average $3.00 on January 9, 2023, about $2.6M. Twelve months later BTMD was up 41%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | BTMD Biote Corp. | Executive Chairman | Buy | 131,950 | $1.53 | $202,203.50 | +122.4% | - | - | |
| Mar 17, 2025 | BTMD Biote Corp. | Director | Buy | 107,794 | $3.87 | $417,162.78 | New | -0.5% | -66.0% | |
| Jan 9, 2023 | BTMD Biote Corp. | Director | Sell | 865,384 | $3.00 | $2,596,152.00 | - | +75.5% | +40.6% | |
| Mar 20, 2017 | NERV Minerva Neurosciences, Inc. | Director | Buy | 50,000 | $8.12 | $405,750.00 | New | - | - |